Enhancement of catecholamine release from PC12 cells by the traditional Japanese medicine, rikkunshito

BMC Complementary and Alternative Medicine

Toshihiko Tsukada²  Yasuhito Uezono⁴  Kiyoshi Terawaki³  Yuko Nagamura¹ 

[1] Present address: JBIC Research Institute, Advanced Industrial Science and Technology, 2-4-7 Aomi, Koto-ku, Tokyo, Japan;Division of Familial Cancer Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan;Present address: Tsumura Research Laboratories, Tsumura & Co, 3586 Yoshiwara, Ami-machi, Inashiki-gun, Ibaraki 300-1192, Japan;Division of Cancer Pathophysiology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan

关键词: cAMP;    PC12;    Catecholamine;    Rikkunshito;   

Others  :  1087256
DOI  :  10.1186/1472-6882-14-256

 received in 2013-08-07, accepted in 2014-07-09,  发布年份 2014

【 摘 要 】

Background

Rikkunshito is a traditional Japanese herbal medicine that is used to treat appetite loss associated with cancer and other disorders. The formulation contains various constituents that influence cell signaling, and rikkunshito may accordingly affect human homeostasis through multiple regulatory pathways, including those governed by the endocrine system. We investigated the actions of rikkunshito on catecholamine release from PC12 cells, an adrenal chromaffin cell line.

Methods

The actions of rikkunshito on PC12 cells were evaluated by measuring intracellular cAMP levels, tyrosine hydroxylase (TH) and vasoactive intestinal peptide (VIP) mRNA expression levels, and catecholamine levels in the culture medium. The transcriptional activation of VIP gene by rikkunshito was assessed by using a VIP promoter-driven reporter gene assay.

Results

Rikkunshito dose-dependently enhanced forskolin-induced elevations in cAMP in PC12 cells, and also increased the gene expression of TH and VIP. The transcriptional activation of VIP gene by rikkunshito was confirmed. Norepinephrine and dopamine secretion into the culture medium of PC12 cells were also dose-dependently augmented by rikkunshito and/or forskolin, but experiments with a protein kinase C (PKC) activator and a phosphodiesterase inhibitor revealed that the effects of rikkunshito were not simply due to the modulation of PKC or phosphodiesterase activity.

Conclusions

These findings suggest that rikkunshito enhances the release of catecholamines by a novel mechanism involving cAMP.

【 授权许可】

   
2014 Nagamura et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Araki Y, Mukaisho K, Fujiyama Y, Hattori T, Sugihara H: The herbal medicine rikkunshito exhibits strong and differential adsorption properties for bile salts. Exp Ther Med 2012, 3:645-649.
• [2]Kawahara H, Kubota A, Hasegawa T, Okuyama H, Ueno T, Ida S, Fukuzawa M: Effects of rikkunshito on the clinical symptoms and esophageal acid exposure in children with symptomatic gastroesophageal reflux. Pediatr Surg Int 2007, 23:1001-1005.
• [3]Okuno S, Hirayama K, Inoue J, Yamasaki K, Kawahara R, Yokoi T, Saeki N, Funato T: Effects of rikkunshito on the postoperative nausea and vomiting (PONV) after laparoscopic gynecological surgery. Masui 2008, 57:1502-1509.
• [4]Shiratori M, Shoji T, Kanazawa M, Hongo M, Fukudo S: Effect of rikkunshito on gastric sensorimotor function under distention. Neurogastroenterol Motil 2011, 23:323-e156.
• [5]Fujitsuka N, Asakawa A, Uezono Y, Minami K, Yamaguchi T, Niijima A, Yada T, Maejima Y, Sedbazar U, Sakai T, Hattori T, Kase Y, Inui A: Potentiation of ghrelin signaling attenuates cancer anorexia-cachexia and prolongs survival. Transl Psychiatry 2011, 1:e23.
• [6]Takeda H, Sadakane C, Hattori T, Katsurada T, Ohkawara T, Nagai K, Asaka M: Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism. Gastroenterology 2008, 134:2004-2013.
• [7]Tomono H, Ito Y, Watanabe T: Successful antiemetic treatment of TSUMURA rikkunshi-to extract granules of ethical use in addition to other antiemetic agents in neoadjuvant chemotherapy for an advanced breast cancer patient. Jpn J Cancer Chemother 2006, 33:1129-1131.
• [8]Yasukawa K, Yu SY, Kakinuma S, Takido M: Inhibitory effect of rikkunshi-to, a traditional Chinese herbal prescription, on tumor promotion in two-stage carcinogenesis in mouse skin. Biol Pharm Bull 1995, 18:730-733.
• [9]Greene LA, Tischler AS: Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci U S A 1976, 73:2424-2428.
• [10]Kim C-H, Koo B-S, Kim K-O, Kim J-K, Chang Y-C, Lee I-S: Salviae miltiorrhizae radix increases dopamine release of rat and pheochromocytoma PC12 cells. Phytother Res 2006, 20:191-199.
• [11]Watano T, Nakazawa K, Obama T, Mori M, Inoue K, Fujimori K, Takanaka A: Non-competitive antagonism by hirsuteine of nicotinic receptor-mediated dopamine release from rat pheochromocytoma cells. Japan J Pharmacol 1993, 61:351-356.
• [12]Kim Y, Choi E-H, Doo M, Kim J-Y, Kim C-J, Kim C-T, Kim I-H: Anti-stress effects of ginseng via down-regulation of tyrosine hydroxylase (TH) and dopamine β-hydroxylase (DBH) gene expression in immobilization-stressed rats and PC12 cells. Nutr Res Pract 2010, 4:270-275.
• [13]Tsukada T, Fukushima M, Takebe H, Nakai Y: Vasoactive intestinal peptide gene expression in the rat pheochromocytoma cell line PC12. Mol Cell Endocrinol 1995, 107:231-239.
• [14]Block T, Kon C, Breckenridge BM: Mutants of PC12 cells with altered cyclic AMP responses. Mol Cell Biol 1984, 4:2091-2097.
• [15]Wessels-Reiker M, Haycock JW, Howlett AC, Strong R: Vasoactive intestinal polypeptide induces tyrosine hydroxylase in PC12 cells. J Biol Chem 1991, 266:9347-9350.
• [16]Baizer L, Weiner N: Regulation of dopamine release from PC12 pheochromocytoma cell cultures during stimulation with elevated potassium or carbachol. J Neurochem 1985, 44:495-501.
• [17]Amer MS, McKinney GR, Akcasu A: Effect of glycyrrhetinic acid on the cyclic nucleotide system of the rat stomach. Biochem Pharmacol 1974, 23:3085-3092.
• [18]Busquets S, Figueras MT, Fuster G, Almendro V, Moore-Carrasco R, Ametller E, Argilés JM, López-Soriano FJ: Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting. Cancer Res 2004, 64:6725-6731.
• [19]Carbó N, López-Soriano J, Tarragó T, González O, Llovera M, López-Soriano FJ, Argilés JM: Comparative effects of β2-adrenergic agonists on muscle waste associated with tumour growth. Cancer Lett 1997, 115:113-118.